Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endosonography | 12 | 2016 | 56 | 1.830 |
Why?
|
| Endoscopes, Gastrointestinal | 12 | 2010 | 12 | 0.910 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 6 | 2016 | 31 | 0.720 |
Why?
|
| Endoscopy, Gastrointestinal | 9 | 2013 | 26 | 0.640 |
Why?
|
| Gallbladder Diseases | 2 | 2010 | 5 | 0.640 |
Why?
|
| Cholestasis | 3 | 2012 | 18 | 0.510 |
Why?
|
| Barrett Esophagus | 1 | 2014 | 3 | 0.500 |
Why?
|
| Precancerous Conditions | 1 | 2014 | 24 | 0.490 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 33 | 0.490 |
Why?
|
| Biliary Tract Diseases | 3 | 2012 | 8 | 0.480 |
Why?
|
| Catheter Ablation | 1 | 2014 | 62 | 0.470 |
Why?
|
| Biliary Tract | 2 | 2012 | 7 | 0.460 |
Why?
|
| Lymphangioma, Cystic | 1 | 2012 | 1 | 0.440 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 301 | 0.400 |
Why?
|
| Pancreatic Diseases | 3 | 2009 | 16 | 0.390 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 131 | 0.380 |
Why?
|
| Polyps | 1 | 2010 | 8 | 0.380 |
Why?
|
| Cholecystectomy | 1 | 2010 | 16 | 0.380 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 88 | 0.360 |
Why?
|
| Liver Diseases | 1 | 2009 | 61 | 0.340 |
Why?
|
| Humans | 41 | 2016 | 29093 | 0.320 |
Why?
|
| Biopsy, Fine-Needle | 4 | 2013 | 50 | 0.300 |
Why?
|
| Liver | 1 | 2009 | 464 | 0.270 |
Why?
|
| Gastrointestinal Diseases | 5 | 2009 | 38 | 0.270 |
Why?
|
| Liver Failure | 1 | 2005 | 17 | 0.260 |
Why?
|
| Stents | 2 | 2009 | 171 | 0.250 |
Why?
|
| Respiratory Mucosa | 1 | 2003 | 10 | 0.230 |
Why?
|
| Mucins | 1 | 2003 | 18 | 0.230 |
Why?
|
| Equipment Design | 11 | 2010 | 167 | 0.220 |
Why?
|
| Sensitivity and Specificity | 5 | 2012 | 532 | 0.210 |
Why?
|
| Epithelial Cells | 1 | 2003 | 138 | 0.210 |
Why?
|
| Catheterization | 3 | 2010 | 58 | 0.200 |
Why?
|
| Device Approval | 2 | 2010 | 6 | 0.190 |
Why?
|
| Colonoscopy | 3 | 2009 | 41 | 0.190 |
Why?
|
| United States Food and Drug Administration | 2 | 2010 | 44 | 0.180 |
Why?
|
| Endoscopy, Digestive System | 2 | 2009 | 9 | 0.170 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 493 | 0.170 |
Why?
|
| Male | 10 | 2016 | 17807 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2008 | 32 | 0.160 |
Why?
|
| Technology Assessment, Biomedical | 4 | 2009 | 10 | 0.150 |
Why?
|
| Digestive System Diseases | 1 | 2016 | 5 | 0.150 |
Why?
|
| Choledocholithiasis | 1 | 2016 | 3 | 0.140 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2016 | 12 | 0.140 |
Why?
|
| Intraoperative Care | 1 | 2016 | 48 | 0.140 |
Why?
|
| Female | 10 | 2016 | 18164 | 0.130 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 12 | 0.120 |
Why?
|
| Sphincterotomy, Endoscopic | 2 | 2010 | 5 | 0.110 |
Why?
|
| Lymphatic Diseases | 1 | 2012 | 9 | 0.110 |
Why?
|
| Surgical Instruments | 2 | 2009 | 20 | 0.110 |
Why?
|
| Equipment Safety | 5 | 2010 | 20 | 0.110 |
Why?
|
| Lymph Nodes | 1 | 2012 | 92 | 0.110 |
Why?
|
| Adult | 5 | 2016 | 8420 | 0.100 |
Why?
|
| Middle Aged | 6 | 2016 | 10829 | 0.100 |
Why?
|
| Video Recording | 2 | 2010 | 52 | 0.100 |
Why?
|
| Intestinal Mucosa | 2 | 2008 | 64 | 0.100 |
Why?
|
| Evidence-Based Medicine | 2 | 2010 | 207 | 0.100 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2010 | 4 | 0.090 |
Why?
|
| Equipment Failure | 1 | 2010 | 22 | 0.090 |
Why?
|
| Pancreatitis, Chronic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Gastrostomy | 1 | 2010 | 17 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 726 | 0.090 |
Why?
|
| Calculi | 1 | 2009 | 3 | 0.090 |
Why?
|
| Gallstones | 1 | 2009 | 9 | 0.090 |
Why?
|
| Cathartics | 1 | 2009 | 4 | 0.090 |
Why?
|
| Microscopy | 1 | 2009 | 27 | 0.090 |
Why?
|
| Hemostasis, Surgical | 1 | 2009 | 13 | 0.090 |
Why?
|
| Disinfection | 1 | 2009 | 5 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 62 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2009 | 18 | 0.090 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2009 | 10 | 0.090 |
Why?
|
| Gallbladder Neoplasms | 1 | 2009 | 33 | 0.090 |
Why?
|
| Bile Duct Neoplasms | 1 | 2009 | 36 | 0.090 |
Why?
|
| Capsule Endoscopy | 1 | 2008 | 3 | 0.080 |
Why?
|
| Gastric Mucosa | 1 | 2008 | 12 | 0.080 |
Why?
|
| Endoscopes | 1 | 2008 | 2 | 0.080 |
Why?
|
| Endoscopy | 1 | 2008 | 40 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2009 | 110 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 21 | 0.080 |
Why?
|
| Radiography | 1 | 2009 | 353 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2008 | 70 | 0.080 |
Why?
|
| Intestine, Small | 1 | 2007 | 34 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 863 | 0.080 |
Why?
|
| Forecasting | 1 | 2008 | 133 | 0.080 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2007 | 7 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 162 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2007 | 30 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 51 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2016 | 3111 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2006 | 23 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 519 | 0.070 |
Why?
|
| Prognosis | 1 | 2010 | 1362 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 787 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2108 | 0.070 |
Why?
|
| Controlled Clinical Trials as Topic | 3 | 2010 | 10 | 0.070 |
Why?
|
| Body Composition | 1 | 2007 | 365 | 0.070 |
Why?
|
| Health Status | 1 | 2006 | 368 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 281 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 208 | 0.060 |
Why?
|
| United States | 5 | 2010 | 3630 | 0.060 |
Why?
|
| Uridine Triphosphate | 1 | 2003 | 1 | 0.060 |
Why?
|
| Adenosine Diphosphate | 1 | 2003 | 5 | 0.060 |
Why?
|
| Goblet Cells | 1 | 2003 | 5 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2003 | 7 | 0.060 |
Why?
|
| Second Messenger Systems | 1 | 2003 | 6 | 0.060 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2003 | 8 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 51 | 0.060 |
Why?
|
| Species Specificity | 1 | 2003 | 84 | 0.060 |
Why?
|
| Bronchi | 1 | 2003 | 41 | 0.060 |
Why?
|
| Adenosine | 1 | 2003 | 41 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2003 | 54 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 121 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 160 | 0.050 |
Why?
|
| Trachea | 1 | 2003 | 55 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2008 | 1305 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2003 | 116 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2003 | 276 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2009 | 3099 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2016 | 501 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2003 | 799 | 0.050 |
Why?
|
| Obesity | 1 | 2007 | 1063 | 0.050 |
Why?
|
| Child | 2 | 2016 | 2219 | 0.040 |
Why?
|
| Needles | 2 | 2009 | 28 | 0.040 |
Why?
|
| Enema | 2 | 2009 | 6 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2016 | 2019 | 0.040 |
Why?
|
| Mice | 1 | 2003 | 2368 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 3717 | 0.040 |
Why?
|
| Cholangiography | 1 | 2016 | 6 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2008 | 464 | 0.030 |
Why?
|
| Animals | 2 | 2010 | 7297 | 0.030 |
Why?
|
| Abdomen | 1 | 2012 | 42 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 1167 | 0.030 |
Why?
|
| Aged | 2 | 2016 | 9487 | 0.030 |
Why?
|
| Compassionate Use Trials | 1 | 2010 | 3 | 0.020 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2010 | 6 | 0.020 |
Why?
|
| Medical Device Recalls | 1 | 2010 | 2 | 0.020 |
Why?
|
| Off-Label Use | 1 | 2010 | 11 | 0.020 |
Why?
|
| Current Procedural Terminology | 1 | 2010 | 4 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 96 | 0.020 |
Why?
|
| Lasers, Gas | 1 | 2009 | 2 | 0.020 |
Why?
|
| Hemostatics | 1 | 2009 | 12 | 0.020 |
Why?
|
| Pancreas | 1 | 2010 | 79 | 0.020 |
Why?
|
| Syringes | 1 | 2009 | 5 | 0.020 |
Why?
|
| Electrocoagulation | 1 | 2009 | 12 | 0.020 |
Why?
|
| Laser Coagulation | 1 | 2009 | 12 | 0.020 |
Why?
|
| Ligation | 1 | 2009 | 55 | 0.020 |
Why?
|
| Device Removal | 1 | 2009 | 31 | 0.020 |
Why?
|
| Dissection | 1 | 2008 | 16 | 0.020 |
Why?
|
| Miniaturization | 1 | 2008 | 5 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 2008 | 14 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 3254 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 39 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2008 | 19 | 0.020 |
Why?
|
| Forms and Records Control | 1 | 2008 | 5 | 0.020 |
Why?
|
| Safety Management | 1 | 2008 | 31 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2008 | 41 | 0.020 |
Why?
|
| Injections | 1 | 2007 | 61 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 89 | 0.020 |
Why?
|
| Safety | 1 | 2007 | 72 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2008 | 149 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 88 | 0.020 |
Why?
|
| Rest | 1 | 2007 | 49 | 0.020 |
Why?
|
| Sigmoidoscopy | 1 | 2006 | 3 | 0.020 |
Why?
|
| Barium Sulfate | 1 | 2006 | 7 | 0.020 |
Why?
|
| Occult Blood | 1 | 2006 | 9 | 0.020 |
Why?
|
| ROC Curve | 1 | 2007 | 149 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2006 | 49 | 0.020 |
Why?
|
| Energy Intake | 1 | 2007 | 120 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 246 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 2009 | 235 | 0.020 |
Why?
|
| Contrast Media | 1 | 2006 | 123 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2007 | 139 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 293 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2006 | 119 | 0.020 |
Why?
|
| Body Weight | 1 | 2007 | 290 | 0.020 |
Why?
|
| Comorbidity | 1 | 2006 | 540 | 0.020 |
Why?
|
| Mass Screening | 1 | 2006 | 223 | 0.020 |
Why?
|
| Motor Activity | 1 | 2007 | 310 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 366 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 610 | 0.010 |
Why?
|